Royalty Pharma plc - Ordinary Shares - Class A
RPRX
Market Cap$19.59B
Close$
$25.18
27.7% downside
Current Fair Value
27.7% downsideOvervalued by 27.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $19.59 Billion |
|---|---|
| Enterprise Value | $26.12 Billion |
| Dividend Yield | $0.86 (2.46842709529277%) |
| Earnings per Share | $1.92 |
| Beta | 0.47 |
| Outstanding Shares | 433,444,937 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.82 |
|---|---|
| PEG | 0.28 |
| Price to Sales | 6.97 |
| Price to Book Ratio | 1.58 |
| Enterprise Value to Revenue | 11.54 |
| Enterprise Value to EBIT | 16.01 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 1.14 |
Revenue Sources
No data
Insider Trades
ESG Score
No data